Table 2. Samples characteristics.
| Number | ||
|---|---|---|
| Parameter | lymphoma (n = 390) | Control (n = 385) |
| Male: female (ratio) | 1.44 | 1.47 |
| Median age (years) | 54(13–85) | 48 (21–85) |
| lymphoma subtypes (WHO) | ||
| B-NHL | 268(68.72%) | |
| T-NHL | 100(25.64%) | |
| HL | 22(5.64%) | |
| Serum LDH, U/L | ||
| Normal | 205(52.56%) | |
| > Normal | 185(47.44%) | |
| Ann Arbor staging | ||
| I + II | 71(18.21%) | |
| III + IV | 319(81.79%) | |
| Bone marrow involvement | ||
| (–) | 334(85.64%) | |
| (+) | 56((14.36%) | |
| B symptoms | ||
| (–) | 309(79.23%) | |
| (+) | 81(20.77%) | |
| IPI | ||
| 0–2 | 249(63.85%) | |
| 3–5 | 141(36.15%) |
Ages are presented as median (range) and the other characteristics are presented as n (%). B-NHL, B-cell non-Hodgkin’s lymphoma; T-NHL, T-cell non-Hodgkin’s lymphoma; HL, Hodgkin’s lymphoma; LDH, Lactate Dehydrogenase; IPI, International Prognostic Index.